Home › Funds › Palo Alto Investors LP › TVTX
Palo Alto Investors LP position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 158,946 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 1.39% of its reported portfolio and ranking #21 among its reported holdings. Palo Alto Investors LP has disclosed TVTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's TVTX position evolved
Palo Alto Investors LP first disclosed a stake in TVTX in Q3 2023 at 166,069 shares (US$1.5M). The position peaked in Q2 2026 at 167,525 shares, worth US$9.5M. Across 13 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 158,946 shares valued at US$9.4M — a reduction of -8,579 shares quarter over quarter.. Notable position changes include a 33% trim in Q4 2023 (shares fell 14% over the following quarter), a 108% increase in Q1 2026 (shares rose 91% over the following quarter), a 27% trim in Q2 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 166.07K | $1.48M | New |
| Q4 2023 | 110.72K | $995.36K | Reduce |
| Q1 2024 | 110.72K | $853.64K | Hold |
| Q2 2024 | 110.72K | $910.11K | Hold |
| Q3 2024 | 110.72K | $1.55M | Hold |
| Q4 2024 | 110.72K | $1.93M | Hold |
| Q1 2025 | 110.72K | $1.98M | Hold |
| Q2 2025 | 110.72K | $1.64M | Hold |
| Q3 2025 | 110.72K | $2.65M | Hold |
| Q4 2025 | 110.72K | $4.23M | Hold |
| Q1 2026 | 230.45K | $6.85M | Add |
| Q2 2026 | 167.53K | $9.52M | Reduce |
| Q3 2026 | 158.95K | $9.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$208.6M), Rock Springs Capital Management LP (US$129.8M), Kynam Capital Management, LP (US$117.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.54M sh · $208.61M · Q3 2026
- Rock Springs Capital Management LP 2.20M sh · $129.78M · Q3 2026
- Kynam Capital Management, LP 2.00M sh · $117.76M · Q3 2026
- Stephens Investment Management Group LLC 1.88M sh · $110.50M · Q3 2026
- EMERALD ADVISERS, LLC 1.56M sh · $92.06M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.53M sh · $90.27M · Q3 2026
- Context Capital Management, LLC 62.70M sh · $73.14M · Q3 2026
- MPM BioImpact LLC 1.09M sh · $64.08M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 984.85K sh · $57.99M · Q3 2026
- Jones Hill Capital LP 959.63K sh · $56.50M · Q3 2026
- ARMISTICE CAPITAL, LLC 720.00K sh · $42.39M · Q3 2026
- Vestal Point Capital, LP 600.00K sh · $35.33M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held TVTX?
Palo Alto Investors LP has disclosed TVTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Palo Alto Investors LP's current position in TVTX?
As of Q3 2026, Palo Alto Investors LP holds 158.95K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $9.36M, representing 1.39% of its reported portfolio and ranking #21.
Has Palo Alto Investors LP been buying or selling TVTX?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in TVTX. The position peaked in Q2 2026 at 167.53K shares.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.